Literature DB >> 11141485

Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology.

J A Wiley1, A Cerwenka, J R Harkema, R W Dutton, A G Harmsen.   

Abstract

This study examined the inflammation, lung function impairment, and immune protection associated with either wild-type or interferon (IFN)-gamma-deficient Tc1- or Tc2-CD8 effector cells responding to influenza pneumonia. The adoptive transfer of influenza hemagglutinin-specific Tc1 effectors afforded protection and elicited only minimal impairment of lung function. IFN-gamma-deficient Tc1 effector cells were equally protective, but were associated with an eosinophil influx and slightly more lung function impairment early in the response. Relative to Tc1, Tc2 effector cells were less protective, elicited an eosinophil influx and a greater impairment of lung functions. IFN-gamma-deficient Tc2 effector cells were not protective and were associated with the severest impairment of lung function throughout the response, an accumulation of neutrophils, and extensive pulmonary vasculitis and alveolar hemorrhaging. Deletion of IFN-gamma was associated with a delay in effector cell recruitment and the elicitation of a more intense inflammatory response that resulted in more severe lung function impairment in the recipients of either Tc1 or Tc2 IFN-gamma-deficient effector cells. Thus, during influenza infections, IFN-gamma production by the responding CD8 T cells is associated with effector cell recruitment and mitigation of the associated inflammation and of the resulting impairment in lung functions but is not necessary for optimal protection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141485      PMCID: PMC1850251          DOI: 10.1016/s0002-9440(10)63950-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Lungkine, a novel CXC chemokine, specifically expressed by lung bronchoepithelial cells.

Authors:  D L Rossi; S D Hurst; Y Xu; W Wang; S Menon; R L Coffman; A Zlotnik
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

Authors:  S Sad; R Marcotte; T R Mosmann
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

3.  CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

Authors:  D J Topham; R A Tripp; P C Doherty
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

4.  A tail artery technic for collecting one-half milliliter of blood from a mouse.

Authors:  B T Fields; D R Cunningham
Journal:  Lab Anim Sci       Date:  1976-06

Review 5.  Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Authors:  P C Doherty; D J Topham; R A Tripp; R D Cardin; J W Brooks; P G Stevenson
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

6.  CD8(+) T cell-mediated spontaneous diabetes in neonatal mice.

Authors:  D J Morgan; R Liblau; B Scott; S Fleck; H O McDevitt; N Sarvetnick; D Lo; L A Sherman
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

7.  Intra-alveolar macrophage-inflammatory peptide 2 induces rapid neutrophil localization in the lung.

Authors:  S Gupta; L Feng; T Yoshimura; J Redick; S M Fu; C E Rose
Journal:  Am J Respir Cell Mol Biol       Date:  1996-11       Impact factor: 6.914

8.  Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.

Authors:  D H Fowler; J Breglio; G Nagel; M A Eckhaus; R E Gress
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

9.  Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease.

Authors:  R I Enelow; A Z Mohammed; M H Stoler; A N Liu; J S Young; Y H Lou; T J Braciale
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

10.  Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model.

Authors:  D Moskophidis; D Kioussis
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  68 in total

1.  Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.

Authors:  Paula A Lanthier; Gail E Huston; Amy Moquin; Sheri M Eaton; Frank M Szaba; Lawrence W Kummer; Micheal P Tighe; Jacob E Kohlmeier; Patrick J Blair; Michael Broderick; Stephen T Smiley; Laura Haynes
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

2.  CD8 T cells utilize TRAIL to control influenza virus infection.

Authors:  Erik L Brincks; Arna Katewa; Tamara A Kucaba; Thomas S Griffith; Kevin L Legge
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Inflammatory impact of IFN-γ in CD8+ T cell-mediated lung injury is mediated by both Stat1-dependent and -independent pathways.

Authors:  Chilakamarti V Ramana; Matthew P DeBerge; Aseem Kumar; Christopher S Alia; Joan E Durbin; Richard I Enelow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-23       Impact factor: 5.464

Review 4.  Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.

Authors:  Annette Fox; Kylie M Quinn; Kanta Subbarao
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

5.  Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection.

Authors:  Kevin B O'Brien; Stacey Schultz-Cherry; Laura J Knoll
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

6.  17β-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs.

Authors:  Dionne P Robinson; Olivia J Hall; Tricia L Nilles; Jay H Bream; Sabra L Klein
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

7.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Critical role of IL-17RA in immunopathology of influenza infection.

Authors:  Christopher R Crowe; Kong Chen; Derek A Pociask; John F Alcorn; Cameron Krivich; Richard I Enelow; Ted M Ross; Joseph L Witztum; Jay K Kolls
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

9.  1918 Influenza virus hemagglutinin (HA) and the viral RNA polymerase complex enhance viral pathogenicity, but only HA induces aberrant host responses in mice.

Authors:  Tokiko Watanabe; Jennifer Tisoncik-Go; Nicolas Tchitchek; Shinji Watanabe; Arndt G Benecke; Michael G Katze; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

10.  Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

Authors:  James A Wiley; Laura E Richert; Steve D Swain; Ann Harmsen; Dale L Barnard; Troy D Randall; Mark Jutila; Trevor Douglas; Chris Broomell; Mark Young; Allen Harmsen
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.